Cost of rotavirus diarrhea for programmatic evaluation of vaccination in Vietnam

Arthorn Riewpaiboon1, Sunheang Shin2,3, Thi Phuong Mai Le4

  • 1Faculty of Pharmacy, Mahidol University, 447 Sri Ayutthaya Road, Ratchathevi, Bangkok, 10400, Thailand. arthorn.rie@mahidol.ac.th.

BMC Public Health
|August 13, 2016
PubMed

Insights

The economic burden of acute gastroenteritis (AGE) in Vietnamese children under five is substantial. Rotavirus infections significantly increase healthcare costs, impacting cost-effectiveness of interventions.

Area of Science:

  • Public Health
  • Health Economics
  • Pediatrics

Background:

  • Rotavirus is a leading cause of diarrhea-related hospitalizations and clinic visits in Vietnamese children under five.
  • Estimating the economic burden of rotavirus-associated healthcare is crucial for public health planning.

Purpose of the Study:

  • To estimate the economic burden of rotavirus-associated formal healthcare encounters in Vietnamese children.
  • To provide updated cost-of-illness data for economic evaluations.

Main Methods:

  • A cost-of-illness study was conducted from a societal perspective.
  • Data collected from 557 children under five with acute gastroenteritis (AGE) symptoms.
  • Resource use and costs obtained via caregiver interviews and medical chart review.

Main Results:

  • The mean total cost of AGE was $175; rotavirus-positive patients incurred higher costs ($217) than rotavirus-negative patients ($158).
  • Rotavirus infection, patient age, and pre-visit oral rehydration solution use significantly affected costs.
  • 41% of enrolled children tested positive for rotavirus.

Conclusions:

  • The study demonstrates a substantial economic burden of AGE, including rotavirus disease, in Vietnam.
  • Updated cost estimates suggest more favorable vaccine cost-effectiveness compared to previous evaluations.
Abstract